{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:28:55Z","timestamp":1791332935914,"version":"4.3.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Retrovirology"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Adult T-cell leukemia (ATL) is an aggressive malignancy of CD4<jats:sup>+<\/jats:sup> T-cells caused by human T-cell leukemia virus type 1 (HTLV-1). The <jats:italic>HTLV-1 bZIP factor<\/jats:italic> (<jats:italic>HBZ<\/jats:italic>) gene, which is encoded by the minus strand of the viral genome, is expressed as an antisense transcript in all ATL cases. By using yeast two-hybrid screening, we identified activating transcription factor 3 (ATF3) as an HBZ-interacting protein. ATF3 has been reported to be expressed in ATL cells, but its biological significance is not known.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Immunoprecipitation analysis confirmed that ATF3 interacts with HBZ. Expression of ATF3 was upregulated in ATL cell lines and fresh ATL cases. Reporter assay revealed that ATF3 could interfere with the HTLV-1 Tax's transactivation of the 5' proviral long terminal repeat (LTR), doing so by affecting the ATF\/CRE site, as well as HBZ. Suppressing ATF3 expression inhibited proliferation and strongly reduced the viability of ATL cells. As mechanisms of growth-promoting activity of ATF3, comparative expression profiling of ATF3 knockdown cells identified candidate genes that are critical for the cell cycle and cell death, including cell division cycle 2 (CDC2) and cyclin E2. ATF3 also enhanced p53 transcriptional activity, but this activity was suppressed by HBZ.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Thus, ATF3 expression has positive and negative effects on the proliferation and survival of ATL cells. HBZ impedes its negative effects, leaving ATF3 to promote proliferation of ATL cells via mechanisms including upregulation of CDC2 and cyclin E2. Both HBZ and ATF3 suppress Tax expression, which enables infected cells to escape the host immune system.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1742-4690-8-19","type":"journal-article","created":{"date-parts":[[2011,3,17]],"date-time":"2011-03-17T19:36:15Z","timestamp":1300390575000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":87,"title":["ATF3, an HTLV-1 bZip factor binding protein, promotes proliferation of adult T-cell leukemia cells"],"prefix":"10.1186","volume":"8","author":[{"given":"Keita","family":"Hagiya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichirou","family":"Yasunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yorifumi","family":"Satou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Ohshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,17]]},"reference":[{"key":"2177_CR1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood.V50.3.481.481","volume":"50","author":"T Uchiyama","year":"1977","unstructured":"Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H: Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977, 50: 481-492.","journal-title":"Blood"},{"key":"2177_CR2","doi-asserted-by":"publisher","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","volume":"77","author":"BJ Poiesz","year":"1980","unstructured":"Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC: Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA. 1980, 77: 7415-7419. 10.1073\/pnas.77.12.7415.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2177_CR3","doi-asserted-by":"publisher","first-page":"6476","DOI":"10.1073\/pnas.78.10.6476","volume":"78","author":"Y Hinuma","year":"1981","unstructured":"Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita KI, Shirakawa S, Miyoshi I: Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA. 1981, 78: 6476-6480. 10.1073\/pnas.78.10.6476.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2177_CR4","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1073\/pnas.79.6.2031","volume":"79","author":"M Yoshida","year":"1982","unstructured":"Yoshida M, Miyoshi I, Hinuma Y: Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA. 1982, 79: 2031-2035. 10.1073\/pnas.79.6.2031.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2177_CR5","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrc2111","volume":"7","author":"M Matsuoka","year":"2007","unstructured":"Matsuoka M, Jeang KT: Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer. 2007, 7: 270-280. 10.1038\/nrc2111.","journal-title":"Nat Rev Cancer"},{"key":"2177_CR6","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1073\/pnas.0507631103","volume":"103","author":"Y Satou","year":"2006","unstructured":"Satou Y, Yasunaga J, Yoshida M, Matsuoka M: HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc Natl Acad Sci USA. 2006, 103: 720-725. 10.1073\/pnas.0507631103.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2177_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1742-4690-6-19","volume":"6","author":"M Saito","year":"2009","unstructured":"Saito M, Matsuzaki T, Satou Y, Yasunaga J, Saito K, Arimura K, Matsuoka M, Ohara Y: In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy\/tropical spastic paraparesis (HAM\/TSP). Retrovirology. 2009, 6: 19-10.1186\/1742-4690-6-19.","journal-title":"Retrovirology"},{"key":"2177_CR8","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.1182\/blood-2008-04-154286","volume":"112","author":"J Arnold","year":"2008","unstructured":"Arnold J, Zimmerman B, Li M, Lairmore MD, Green PL: Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation. Blood. 2008, 112: 3788-3797. 10.1182\/blood-2008-04-154286.","journal-title":"Blood"},{"key":"2177_CR9","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1128\/JVI.80.5.2495-2505.2006","volume":"80","author":"K Murata","year":"2006","unstructured":"Murata K, Hayashibara T, Sugahara K, Uemura A, Yamaguchi T, Harasawa H, Hasegawa H, Tsuruda K, Okazaki T, Koji T, et al: A novel alternative splicing isoform of human T-cell leukemia virus type 1 bZIP factor (HBZ-SI) targets distinct subnuclear localization. J Virol. 2006, 80: 2495-2505. 10.1128\/JVI.80.5.2495-2505.2006.","journal-title":"J Virol"},{"key":"2177_CR10","doi-asserted-by":"publisher","first-page":"12813","DOI":"10.1128\/JVI.76.24.12813-12822.2002","volume":"76","author":"G Gaudray","year":"2002","unstructured":"Gaudray G, Gachon F, Basbous J, Biard-Piechaczyk M, Devaux C, Mesnard JM: The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription. J Virol. 2002, 76: 12813-12822. 10.1128\/JVI.76.24.12813-12822.2002.","journal-title":"J Virol"},{"key":"2177_CR11","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/0006-291X(89)92322-X","volume":"163","author":"D Larocca","year":"1989","unstructured":"Larocca D, Chao LA, Seto MH, Brunck TK: Human T-cell leukemia virus minus strand transcription in infected T-cells. Biochem Biophys Res Commun. 1989, 163: 1006-1013. 10.1016\/0006-291X(89)92322-X.","journal-title":"Biochem Biophys Res Commun"},{"key":"2177_CR12","doi-asserted-by":"publisher","first-page":"9359","DOI":"10.1128\/JVI.00242-08","volume":"82","author":"M Yoshida","year":"2008","unstructured":"Yoshida M, Satou Y, Yasunaga J, Fujisawa J, Matsuoka M: Transcriptional control of spliced and unspliced human T-cell leukemia virus type 1 bZIP factor (HBZ) gene. J Virol. 2008, 82: 9359-9368. 10.1128\/JVI.00242-08.","journal-title":"J Virol"},{"key":"2177_CR13","doi-asserted-by":"publisher","first-page":"43620","DOI":"10.1074\/jbc.M307275200","volume":"278","author":"J Basbous","year":"2003","unstructured":"Basbous J, Arpin C, Gaudray G, Piechaczyk M, Devaux C, Mesnard JM: The HBZ factor of human T-cell leukemia virus type I dimerizes with transcription factors JunB and c-Jun and modulates their transcriptional activity. J Biol Chem. 2003, 278: 43620-43627. 10.1074\/jbc.M307275200.","journal-title":"J Biol Chem"},{"key":"2177_CR14","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1128\/JVI.00480-06","volume":"81","author":"I Lemasson","year":"2007","unstructured":"Lemasson I, Lewis MR, Polakowski N, Hivin P, Cavanagh MH, Thebault S, Barbeau B, Nyborg JK, Mesnard JM: Human T-cell leukemia virus type 1 (HTLV-1) bZIP protein interacts with the cellular transcription factor CREB to inhibit HTLV-1 transcription. J Virol. 2007, 81: 1543-1553. 10.1128\/JVI.00480-06.","journal-title":"J Virol"},{"key":"2177_CR15","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0014-5793(04)00225-X","volume":"562","author":"S Thebault","year":"2004","unstructured":"Thebault S, Basbous J, Hivin P, Devaux C, Mesnard JM: HBZ interacts with JunD and stimulates its transcriptional activity. FEBS Lett. 2004, 562: 165-170. 10.1016\/S0014-5793(04)00225-X.","journal-title":"FEBS Lett"},{"key":"2177_CR16","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/sj.onc.1208297","volume":"24","author":"J Matsumoto","year":"2005","unstructured":"Matsumoto J, Ohshima T, Isono O, Shimotohno K: HTLV-1 HBZ suppresses AP-1 activity by impairing both the DNA-binding ability and the stability of c-Jun protein. Oncogene. 2005, 24: 1001-1010. 10.1038\/sj.onc.1208297.","journal-title":"Oncogene"},{"key":"2177_CR17","doi-asserted-by":"publisher","first-page":"34273","DOI":"10.1074\/jbc.M802527200","volume":"283","author":"O Isono","year":"2008","unstructured":"Isono O, Ohshima T, Saeki Y, Matsumoto J, Hijikata M, Tanaka K, Shimotohno K: Human T-cell leukemia virus type 1 HBZ protein bypasses the targeting function of ubiquitination. J Biol Chem. 2008, 283: 34273-34282. 10.1074\/jbc.M802527200.","journal-title":"J Biol Chem"},{"key":"2177_CR18","first-page":"321","volume":"7","author":"T Hai","year":"1999","unstructured":"Hai T, Wolfgang CD, Marsee DK, Allen AE, Sivaprasad U: ATF3 and stress responses. Gene Expr. 1999, 7: 321-335.","journal-title":"Gene Expr"},{"key":"2177_CR19","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1038\/cdd.2008.74","volume":"15","author":"L Turchi","year":"2008","unstructured":"Turchi L, Aberdam E, Mazure N, Pouyssegur J, Deckert M, Kitajima S, Aberdam D, Virolle T: Hif-2alpha mediates UV-induced apoptosis through a novel ATF3-dependent death pathway. Cell Death Differ. 2008, 15: 1472-1480. 10.1038\/cdd.2008.74.","journal-title":"Cell Death Differ"},{"key":"2177_CR20","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/sj.onc.1209781","volume":"26","author":"K Ameri","year":"2007","unstructured":"Ameri K, Hammond EM, Culmsee C, Raida M, Katschinski DM, Wenger RH, Wagner E, Davis RJ, Hai T, Denko N, Harris AL: Induction of activating transcription factor 3 by anoxia is independent of p53 and the hypoxic HIF signalling pathway. Oncogene. 2007, 26: 284-289. 10.1038\/sj.onc.1209781.","journal-title":"Oncogene"},{"key":"2177_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0378-1119(01)00551-0","volume":"273","author":"T Hai","year":"2001","unstructured":"Hai T, Hartman MG: The molecular biology and nomenclature of the activating transcription factor\/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis. Gene. 2001, 273: 1-11. 10.1016\/S0378-1119(01)00551-0.","journal-title":"Gene"},{"key":"2177_CR22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nature04768","volume":"441","author":"M Gilchrist","year":"2006","unstructured":"Gilchrist M, Thorsson V, Li B, Rust AG, Korb M, Roach JC, Kennedy K, Hai T, Bolouri H, Aderem A: Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature. 2006, 441: 173-178. 10.1038\/nature04768.","journal-title":"Nature"},{"key":"2177_CR23","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1038\/sj.onc.1210861","volume":"27","author":"X Yin","year":"2008","unstructured":"Yin X, Dewille JW, Hai T: A potential dichotomous role of ATF3, an adaptive-response gene, in cancer development. Oncogene. 2008, 27: 2118-2127. 10.1038\/sj.onc.1210861.","journal-title":"Oncogene"},{"key":"2177_CR24","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1182\/blood-2005-07-2694","volume":"107","author":"M Janz","year":"2006","unstructured":"Janz M, Hummel M, Truss M, Wollert-Wulf B, Mathas S, Johrens K, Hagemeier C, Bommert K, Stein H, Dorken B, Bargou RC: Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3), which promotes viability of Hodgkin\/Reed-Sternberg cells. Blood. 2006, 107: 2536-2539. 10.1182\/blood-2005-07-2694.","journal-title":"Blood"},{"key":"2177_CR25","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/S0022-5347(05)00651-8","volume":"175","author":"AE Pelzer","year":"2006","unstructured":"Pelzer AE, Bektic J, Haag P, Berger AP, Pycha A, Schafer G, Rogatsch H, Horninger W, Bartsch G, Klocker H: The expression of transcription factor activating transcription factor 3 in the human prostate and its regulation by androgen in prostate cancer. J Urol. 2006, 175: 1517-1522. 10.1016\/S0022-5347(05)00651-8.","journal-title":"J Urol"},{"key":"2177_CR26","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/mc.20298","volume":"46","author":"A Wang","year":"2007","unstructured":"Wang A, Arantes S, Conti C, McArthur M, Aldaz CM, MacLeod MC: Epidermal hyperplasia and oral carcinoma in mice overexpressing the transcription factor ATF3 in basal epithelial cells. Mol Carcinog. 2007, 46: 476-487. 10.1002\/mc.20298.","journal-title":"Mol Carcinog"},{"key":"2177_CR27","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.leukres.2008.11.006","volume":"33","author":"M Kamioka","year":"2009","unstructured":"Kamioka M, Imamura J, Komatsu N, Daibata M, Sugiura T: Testican 3 expression in adult T-cell leukemia. Leuk Res. 2009, 33: 913-918. 10.1016\/j.leukres.2008.11.006.","journal-title":"Leuk Res"},{"key":"2177_CR28","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1182\/blood-2008-06-161729","volume":"113","author":"T Zhao","year":"2009","unstructured":"Zhao T, Yasunaga J, Satou Y, Nakao M, Takahashi M, Fujii M, Matsuoka M: Human T-cell leukemia virus type 1 bZIP factor selectively suppresses the classical pathway of NF-kappaB. Blood. 2009, 113: 2755-2764. 10.1182\/blood-2008-06-161729.","journal-title":"Blood"},{"key":"2177_CR29","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/sj.onc.1204200","volume":"20","author":"S Perez","year":"2001","unstructured":"Perez S, Vial E, van Dam H, Castellazzi M: Transcription factor ATF3 partially transforms chick embryo fibroblasts by promoting growth factor-independent proliferation. Oncogene. 2001, 20: 1135-1141. 10.1038\/sj.onc.1204200.","journal-title":"Oncogene"},{"key":"2177_CR30","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1038\/sj.emboj.7600742","volume":"24","author":"K Tamura","year":"2005","unstructured":"Tamura K, Hua B, Adachi S, Guney I, Kawauchi J, Morioka M, Tamamori-Adachi M, Tanaka Y, Nakabeppu Y, Sunamori M, et al: Stress response gene ATF3 is a target of c-myc in serum-induced cell proliferation. EMBO J. 2005, 24: 2590-2601. 10.1038\/sj.emboj.7600742.","journal-title":"EMBO J"},{"key":"2177_CR31","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1038\/sj.emboj.7600712","volume":"24","author":"C Yan","year":"2005","unstructured":"Yan C, Lu D, Hai T, Boyd DD: Activating transcription factor 3, a stress sensor, activates p53 by blocking its ubiquitination. EMBO J. 2005, 24: 2425-2435. 10.1038\/sj.emboj.7600712.","journal-title":"EMBO J"},{"key":"2177_CR32","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1093\/nar\/gkn1082","volume":"37","author":"K Miyazaki","year":"2009","unstructured":"Miyazaki K, Inoue S, Yamada K, Watanabe M, Liu Q, Watanabe T, Adachi MT, Tanaka Y, Kitajima S: Differential usage of alternate promoters of the human stress response gene ATF3 in stress response and cancer cells. Nucleic Acids Res. 2009, 37: 1438-1451. 10.1093\/nar\/gkn1082.","journal-title":"Nucleic Acids Res"},{"key":"2177_CR33","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1074\/jbc.271.3.1695","volume":"271","author":"G Liang","year":"1996","unstructured":"Liang G, Wolfgang CD, Chen BP, Chen TH, Hai T: ATF3 gene. Genomic organization, promoter, and regulation. J Biol Chem. 1996, 271: 1695-1701. 10.1074\/jbc.271.3.1695.","journal-title":"J Biol Chem"},{"key":"2177_CR34","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1128\/jvi.63.8.3234-3239.1989","volume":"63","author":"J Fujisawa","year":"1989","unstructured":"Fujisawa J, Toita M, Yoshida M: A unique enhancer element for the trans activator (p40tax) of human T-cell leukemia virus type I that is distinct from cyclic AMP- and 12-O-tetradecanoylphorbol-13-acetate-responsive elements. J Virol. 1989, 63: 3234-3239.","journal-title":"J Virol"},{"key":"2177_CR35","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1073\/pnas.90.2.610","volume":"90","author":"T Suzuki","year":"1993","unstructured":"Suzuki T, Fujisawa JI, Toita M, Yoshida M: The trans-activator tax of human T-cell leukemia virus type 1 (HTLV-1) interacts with cAMP-responsive element (CRE) binding and CRE modulator proteins that bind to the 21-base-pair enhancer of HTLV-1. Proc Natl Acad Sci USA. 1993, 90: 610-614. 10.1073\/pnas.90.2.610.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2177_CR36","doi-asserted-by":"crossref","first-page":"15819","DOI":"10.1016\/S0021-9258(17)40754-X","volume":"269","author":"BP Chen","year":"1994","unstructured":"Chen BP, Liang G, Whelan J, Hai T: ATF3 and ATF3 delta Zip. Transcriptional repression versus activation by alternatively spliced isoforms. J Biol Chem. 1994, 269: 15819-15826.","journal-title":"J Biol Chem"},{"key":"2177_CR37","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/ncb1284","volume":"7","author":"E Aleem","year":"2005","unstructured":"Aleem E, Kiyokawa H, Kaldis P: Cdc2-cyclin E complexes regulate the G1\/S phase transition. Nat Cell Biol. 2005, 7: 831-836. 10.1038\/ncb1284.","journal-title":"Nat Cell Biol"},{"key":"2177_CR38","doi-asserted-by":"publisher","first-page":"926","DOI":"10.4161\/cc.5.9.2714","volume":"5","author":"C Yan","year":"2006","unstructured":"Yan C, Boyd DD: ATF3 regulates the stability of p53: a link to cancer. Cell Cycle. 2006, 5: 926-929. 10.4161\/cc.5.9.2714.","journal-title":"Cell Cycle"},{"key":"2177_CR39","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/107327480701400206","volume":"14","author":"J Yasunaga","year":"2007","unstructured":"Yasunaga J, Matsuoka M: Human T-cell leukemia virus type I induces adult T-cell leukemia: from clinical aspects to molecular mechanisms. Cancer Control. 2007, 14: 133-140.","journal-title":"Cancer Control"},{"key":"2177_CR40","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/intimm\/3.8.761","volume":"3","author":"M Kannagi","year":"1991","unstructured":"Kannagi M, Harada S, Maruyama I, Inoko H, Igarashi H, Kuwashima G, Sato S, Morita M, Kidokoro M, Sugimoto M, et al: Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells. Int Immunol. 1991, 3: 761-767. 10.1093\/intimm\/3.8.761.","journal-title":"Int Immunol"},{"key":"2177_CR41","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrc2602","volume":"9","author":"M Malumbres","year":"2009","unstructured":"Malumbres M, Barbacid M: Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer. 2009, 9: 153-166. 10.1038\/nrc2602.","journal-title":"Nat Rev Cancer"},{"key":"2177_CR42","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S1357-2725(01)00137-6","volume":"34","author":"M Payton","year":"2002","unstructured":"Payton M, Coats S: Cyclin E2, the cycle continues. Int J Biochem Cell Biol. 2002, 34: 315-320. 10.1016\/S1357-2725(01)00137-6.","journal-title":"Int J Biochem Cell Biol"},{"key":"2177_CR43","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1182\/blood.V79.2.477.477","volume":"79","author":"A Sakashita","year":"1992","unstructured":"Sakashita A, Hattori T, Miller CW, Suzushima H, Asou N, Takatsuki K, Koeffler HP: Mutations of the p53 gene in adult T-cell leukemia. Blood. 1992, 79: 477-480.","journal-title":"Blood"},{"key":"2177_CR44","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1182\/blood.V80.12.3205.3205","volume":"80","author":"E Cesarman","year":"1992","unstructured":"Cesarman E, Chadburn A, Inghirami G, Gaidano G, Knowles DM: Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia\/lymphoma shows frequent p53 mutations. Blood. 1992, 80: 3205-3216.","journal-title":"Blood"},{"key":"2177_CR45","first-page":"598","volume":"9","author":"S Nishimura","year":"1995","unstructured":"Nishimura S, Asou N, Suzushima H, Okubo T, Fujimoto T, Osato M, Yamasaki H, Lisha L, Takatsuki K: p53 gene mutation and loss of heterozygosity are associated with increased risk of disease progression in adult T cell leukemia. Leukemia. 1995, 9: 598-604.","journal-title":"Leukemia"},{"key":"2177_CR46","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1182\/blood.V95.12.3939.012k30_3939_3944","volume":"95","author":"S Takemoto","year":"2000","unstructured":"Takemoto S, Trovato R, Cereseto A, Nicot C, Kislyakova T, Casareto L, Waldmann T, Torelli G, Franchini G: p53 stabilization and functional impairment in the absence of genetic mutation or the alteration of the p14(ARF)-MDM2 loop in ex vivo and cultured adult T-cell leukemia\/lymphoma cells. Blood. 2000, 95: 3939-3944.","journal-title":"Blood"},{"key":"2177_CR47","doi-asserted-by":"publisher","first-page":"31991","DOI":"10.1074\/jbc.R400009200","volume":"279","author":"KT Jeang","year":"2004","unstructured":"Jeang KT, Giam CZ, Majone F, Aboud M: Life, death, and tax: role of HTLV-I oncoprotein in genetic instability and cellular transformation. J Biol Chem. 2004, 279: 31991-31994. 10.1074\/jbc.R400009200.","journal-title":"J Biol Chem"},{"key":"2177_CR48","doi-asserted-by":"publisher","first-page":"4137","DOI":"10.1038\/sj.onc.1202766","volume":"18","author":"T Suzuki","year":"1999","unstructured":"Suzuki T, Uchida-Toita M, Yoshida M: Tax protein of HTLV-1 inhibits CBP\/p300-mediated transcription by interfering with recruitment of CBP\/p300 onto DNA element of E-box or p53 binding site. Oncogene. 1999, 18: 4137-4143. 10.1038\/sj.onc.1202766.","journal-title":"Oncogene"},{"key":"2177_CR49","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/carcin\/bgi274","volume":"27","author":"Y Tabakin-Fix","year":"2006","unstructured":"Tabakin-Fix Y, Azran I, Schavinky-Khrapunsky Y, Levy O, Aboud M: Functional inactivation of p53 by human T-cell leukemia virus type 1 Tax protein: mechanisms and clinical implications. Carcinogenesis. 2006, 27: 673-681. 10.1093\/carcin\/bgi274.","journal-title":"Carcinogenesis"},{"key":"2177_CR50","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/ijc.20007","volume":"109","author":"S Takeda","year":"2004","unstructured":"Takeda S, Maeda M, Morikawa S, Taniguchi Y, Yasunaga J, Nosaka K, Tanaka Y, Matsuoka M: Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells. Int J Cancer. 2004, 109: 559-567. 10.1002\/ijc.20007.","journal-title":"Int J Cancer"},{"issue":"14","key":"2177_CR51","doi-asserted-by":"publisher","first-page":"7278","DOI":"10.1128\/JVI.02239-09","volume":"84","author":"J Fan","year":"2010","unstructured":"Fan J, Ma G, Nosaka K, Tanabe J, Satou Y, Koito A, Wain-Hobson S, Vartanian JP, Matsuoka M: APOBEC3G Generates Nonsense Mutations in HTLV-1 Proviral Genomes In Vivo. J Virol. 2010, 84 (14): 7278-87. 10.1128\/JVI.02239-09. Epub 2010 May 12","journal-title":"J Virol"},{"key":"2177_CR52","doi-asserted-by":"publisher","first-page":"e116","DOI":"10.1371\/journal.ppat.0020116","volume":"2","author":"QL Cai","year":"2006","unstructured":"Cai QL, Knight JS, Verma SC, Zald P, Robertson ES: EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors. PLoS Pathog. 2006, 2: e116-10.1371\/journal.ppat.0020116.","journal-title":"PLoS Pathog"},{"key":"2177_CR53","doi-asserted-by":"publisher","first-page":"13201","DOI":"10.1074\/jbc.M109.058669","volume":"285","author":"H Wang","year":"2010","unstructured":"Wang H, Mo P, Ren S, Yan C: Activating transcription factor 3 activates p53 by preventing E6-associated protein from binding to E6. J Biol Chem. 2010, 285: 13201-13210. 10.1074\/jbc.M109.058669.","journal-title":"J Biol Chem"},{"key":"2177_CR54","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/0092-8674(93)90500-P","volume":"75","author":"WS el-Deiry","year":"1993","unstructured":"el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell. 1993, 75: 817-825. 10.1016\/0092-8674(93)90500-P.","journal-title":"Cell"},{"key":"2177_CR55","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983, 65: 55-63. 10.1016\/0022-1759(83)90303-4.","journal-title":"J Immunol Methods"}],"container-title":["Retrovirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-4690-8-19.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T13:11:23Z","timestamp":1630501883000},"score":1,"resource":{"primary":{"URL":"https:\/\/retrovirology.biomedcentral.com\/articles\/10.1186\/1742-4690-8-19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,17]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["2177"],"URL":"https:\/\/doi.org\/10.1186\/1742-4690-8-19","relation":{},"ISSN":["1742-4690"],"issn-type":[{"value":"1742-4690","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,17]]},"assertion":[{"value":"20 November 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"19"}}